Walden Group Healthcare M&A Blog

QIAGEN Acquires NeuMoDx Molecular for $248m

9/29/2020
Netherlands-based QIAGEN N.V. (NYSE: QGEN), a $1.5b developer of molecular diagnostic equipment and assays, has acquired a 80.1% ownership stake in diagnostics instruments maker NeuMoDx Molecular, Inc. for $248m. Qiagen had purchased a 19.9% ownership stake in NeuMoDx in 2018. The acquisition builds on QIAGEN’s portfolio of automated...
Read More
Intersect ENT to Acquire Fiagon AG Medical Technologie

9/25/2020
Intersect ENT (Nasdaq: XENT), a $109.1m developer of sinus implants and other ENT-focused products is acquiring Germany-based Fiagon, a developer of proprietary, electromagnetic-based ENT surgical navigation systems for $71.2m. Fiagon’s instruments, produced in Germany, are tip-tracked, enabling surgeons to monitor the full range of...
Read More
Bruker To Acquire Canopy Biosciences

9/14/2020
Bruker Corp. (Nasdaq: BRKR), a $2.1b manufacturer of analytical and diagnostic platforms and instruments is acquiring Canopy Biosciences, a developer of multiplex biomarker imaging technologies for immunology, immuno-oncology and cell therapy to boost Bruker’s CRISPR (clustered regularly interspaced short palindromic repeats) gene editing...
Read More
Royal Philips to Acquire Intact Vascular for $360m

9/8/2020
Koninklijke Philips NV (Royal Philips) (NYSE: PHG), a $19.5b Netherlands-based producer of medical technologies and imaging platforms is acquiring Intact Vascular, Inc., a developer of a minimally invasive implantable device to treat Peripheral Artery Disease (PAD), when narrowed blood vessels restrict blood flow to limbs. The acquisition...
Read More
Hologic Acquires Acessa Health for $80M

9/1/2020
Hologic (Nasdaq: HOLX), a $3.4b developer of diagnostics, imaging systems, surgical products, and light-based aesthetic and medical treatment platforms for women is buying Acessa Health, the developer of the Acessa ProVu system, a laparoscopic device combining radiofrequency ablation and advanced intra-abdominal ultrasound to treat benign uterine...
Read More